Navigation Links
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Date:8/19/2007

membership agreements, customized IT systems, and an integrated tissue bank. For more information, please visit http://www.themmrc.org.

About Proteolix

Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers and immunological conditions by inhibiting the proteasome and thereby disrupting protein turnover in cells. In addition to its lead product candidate, carfilzomib (PR-171), which is delivered intravenously and is currently in multiple clinical trials to evaluate its safety and efficacy in different types of cancer, Proteolix is developing next generation proteasome inhibitors, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor, to expand the therapeutic potential of this new target class. Proteolix is headquartered in South San Francisco. For more information, please visit the Company's website at http://www.proteolix.com.

MMRC Contact: Anne Quinn Young, Program Director, 203-652-0212

Proteolix Contact: Stephen R. Brady, Executive Director of Business & Legal Affairs, 650-615-7521


'/>"/>
SOURCE Proteolix

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... YORK , Dec. 18, 2014 Somewhere ... addressing hearing health was forgotten. But Audicus , ... to hear better this new year. Hearing ... facing the aging population, though it is often unaddressed. ... in four has a hearing aid, mainly due to ...
(Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
(Date:12/19/2014)... , Dec. 18, 2014   Aratana ... a biopharmaceutical company focused on the licensing, development ... today announced positive results from its pivotal field ... for treating pain in dogs with osteoarthritis.  In ... pain assessment scores that were statistically significant compared ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... Nov. 2, 2010 Cambrex Corporation (NYSE: CBM ... Zenara Pharma, a Hyderabad, India based pharmaceutical company focused on ... Highlights To be named ... global suppliers to the large and growing Nicotine Replacement Therapy ...
... Charleston Laboratories, Inc., an emerging specialty pharmaceutical ... (OINV) in opioid pharmaceuticals, announced today that it ... government under the Qualifying Therapeutic Discovery Project (QTDP) ... award to advance the development of its lead ...
Cached Medicine Technology:Cambrex Acquires Stake in Zenara Pharma 2Cambrex Acquires Stake in Zenara Pharma 3Cambrex Acquires Stake in Zenara Pharma 4Charleston Laboratories, Inc. Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant Under the U.S. Patient Protection and Affordable Care Act of 2010 2
(Date:12/20/2014)... 2014 Weddingshe.com has recently announced its ... site-wide promotion of special occasion dresses for the coming ... of special occasion dresses for global women. Now, all ... discounts, up to 80% off. Among the new items, ... Sweet 16 Dress) is very popular. What’s more, Weddingshe.com ...
(Date:12/20/2014)... DePuy Pinnacle hip lawsuits ( ... the artificial hip system was defectively designed continue ... Bernstein Liebhard LLP reports. According to an Order ... on December 2nd, counsel in 10 DePuy Pinnacle ... on November 19, 2014, with depositions to conclude ...
(Date:12/20/2014)... 2014 Recently, VogueQueen.com, a leading wedding ... Big Sale Online for 2015. Great discounts are ... and old consumers can get a discount, up to ... company’s website before January 30, 2015. , VogueQueen.com has ... launched a prom dress promotion. Many customers worldwide like ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 As ... move forward in U.S. courts, Bernstein Liebhard LLP ... suggests that children treated with the medication may ... to breast development and lactation. The study, which ... children and adolescents who began treatment with risperidone, ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special ... the coming Christmas. In the promotion, all buyers worldwide ... “We have something special for the women who are ... Moreover, our new collections of 2015 dresses have been ... at greatly discounted prices. Visit our website now before ...
Breaking Medicine News(10 mins):Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... ARLINGTON, Va., Jan. 8 A congressionally mandated "competitive ... slowest-rising cost in Medicare -- intended to reduce homecare ... and access to, care for patients and will drive ... columnist George F. Will,s recent column on healthcare ...
... WASHINGTON, Jan. 8 /PRNewswire-USNewswire/ -- Advocates ... sexual and reproductive health, has released an analysis ... U.S. lag far behind those in France, Germany, ... , The U.S. teen birth rate, for ...
... CHAPEL HILL, N.C., Jan. 8 Many companies ... to the unstable economic environment. More than,ever will ... to manage its,biggest asset -- customers. To excel ... must master many fronts: creating effective customer,listening posts, ...
... brings together public-private sector members to achieve ... The National eHealth Collaborative, formerly AHIC ... Washington, D.C. The National eHealth Collaborative ... creation of a secure, interoperable, nationwide health ...
... lead to extended life spans , , THURSDAY, Jan. 8 ... previously thought-to-be-separate pathways tied to aging, at least in ... is an orderly and deliberate genetic occurrence. , ... extend life and delay aging, the researchers said. , ...
... of skin cancer, researchers suggest , , THURSDAY, Jan. 8 ... cancer melanoma are increasing among men and women in ... , Whether the increase in melanoma signals an epidemic ... increasing among all Americans and cannot be due to ...
Cached Medicine News:Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 2Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 3Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 4Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 2Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 3Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2Health News:National eHealth Collaborative Launched 2Health News:National eHealth Collaborative Launched 3Health News:National eHealth Collaborative Launched 4Health News:National eHealth Collaborative Launched 5Health News:National eHealth Collaborative Launched 6Health News:Researchers Gain Insights Into Aging in Mice 2Health News:Melanoma Rates on the Rise in U.S. 2Health News:Melanoma Rates on the Rise in U.S. 3
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Nerve Electrodes provide direct cranial nerve ... patented circumferential design provides sensitive contact ... stable real-time recordings. This unique approach ... the removal of acoustic neuromas, microvascular ...
... Ad-Techs Model CMU Cortical Mapping Unit ... of recording EEGs from exposed cortex during ... each electrode plate can be positioned independently ... clamp provides two alternative mounting locations and ...
An ambulatory recorder can help the patient be more comfortable and at ease as well as increasing an EEG laboratory's recording capacity....
Medicine Products: